These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 30834253
21. [Alprazolam versus lorazepam in the treatment of anxiety: controlled clinical study]. Bernardi F, Fossi L, Faravelli C, Corsini GU, Varricchio MC. Riv Patol Nerv Ment; 1984; 105(1):1-13. PubMed ID: 6571441 [Abstract] [Full Text] [Related]
22. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study. Sarris J, Stough C, Bousman CA, Wahid ZT, Murray G, Teschke R, Savage KM, Dowell A, Ng C, Schweitzer I. J Clin Psychopharmacol; 2013 Oct; 33(5):643-8. PubMed ID: 23635869 [Abstract] [Full Text] [Related]
23. Isolation of nor-secofriedelanes from the sedative extracts of Galphimia glauca. Cardoso Taketa AT, Lozada-Lechuga J, Fragoso-Serrano M, Villarreal ML, Pereda-Miranda R. J Nat Prod; 2004 Apr; 67(4):644-9. PubMed ID: 15104495 [Abstract] [Full Text] [Related]
24. Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study. Cohn JB, Wilcox CS. J Clin Psychiatry; 1986 Aug; 47(8):409-12. PubMed ID: 2874128 [Abstract] [Full Text] [Related]
25. [Medicinal plants for the treatment of generalized anxiety disorder: a review of controlled clinical studies]. Faustino TT, Almeida RB, Andreatini R. Braz J Psychiatry; 2010 Dec; 32(4):429-36. PubMed ID: 21308265 [Abstract] [Full Text] [Related]
26. Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine. Klein E, Colin V, Stolk J, Lenox RH. Am J Psychiatry; 1994 Dec; 151(12):1760-6. PubMed ID: 7977882 [Abstract] [Full Text] [Related]
27. Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms. Hoehn-Saric R, McLeod DR, Zimmerli WD. J Clin Psychiatry; 1988 Aug; 49(8):293-301. PubMed ID: 3045099 [Abstract] [Full Text] [Related]
28. Alprazolam in the treatment of neurotic anxiety. Kerry RJ, McDermott CM. Pharmatherapeutica; 1983 Aug; 3(7):451-5. PubMed ID: 6142462 [Abstract] [Full Text] [Related]
29. Norsecofriedelanes as spasmolytics, advances of structure-activity relationships. González-Cortazar M, Tortoriello J, Alvarez L. Planta Med; 2005 Aug; 71(8):711-6. PubMed ID: 16142633 [Abstract] [Full Text] [Related]
30. Concurrent use of buspirone in anxious patients during withdrawal from alprazolam therapy. Udelman HD, Udelman DL. J Clin Psychiatry; 1990 Sep; 51 Suppl():46-50. PubMed ID: 2211568 [Abstract] [Full Text] [Related]
31. Interaction of the natural anxiolytic Galphimine-B with serotonergic drugs on dorsal hippocampus in rats. Jiménez-Ferrer E, Herrera-Ruiz M, Ramírez-García R, Herrera-Arellano A, Tortoriello J. J Ethnopharmacol; 2011 Sep 01; 137(1):724-9. PubMed ID: 21742023 [Abstract] [Full Text] [Related]
32. Ginkgo biloba special extract EGb 761 in generalized anxiety disorder and adjustment disorder with anxious mood: a randomized, double-blind, placebo-controlled trial. Woelk H, Arnoldt KH, Kieser M, Hoerr R. J Psychiatr Res; 2007 Sep 01; 41(6):472-80. PubMed ID: 16808927 [Abstract] [Full Text] [Related]
33. Double-blind, randomised, placebo-controlled study to evaluate the efficacy and safety of a fixed combination containing two plant extracts (Crataegus oxyacantha and Eschscholtzia californica) and magnesium in mild-to-moderate anxiety disorders. Hanus M, Lafon J, Mathieu M. Curr Med Res Opin; 2004 Jan 01; 20(1):63-71. PubMed ID: 14741074 [Abstract] [Full Text] [Related]
34. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group. Lydiard RB, Ballenger JC, Rickels K. J Clin Psychiatry; 1997 Jan 01; 58 Suppl 11():11-8. PubMed ID: 9363043 [Abstract] [Full Text] [Related]
35. Further galphimines from a new population of Galphimia glauca. Ortega A, Pastor-Palacios G, Ortiz-Pastrana N, Ávila-Cabezas E, Toscano RA, Joseph-Nathan P, Morales-Jiménez J, Bautista E. Phytochemistry; 2020 Jan 01; 169():112180. PubMed ID: 31634725 [Abstract] [Full Text] [Related]
36. The comparative clinical study of efficacy of Gamisoyo-San (Jiaweixiaoyaosan) on generalized anxiety disorder according to differently manufactured preparations: multicenter, randomized, double blind, placebo controlled trial. Park DM, Kim SH, Park YC, Kang WC, Lee SR, Jung IC. J Ethnopharmacol; 2014 Dec 02; 158 Pt A():11-7. PubMed ID: 25456420 [Abstract] [Full Text] [Related]
37. An open label trial of alprazolam in comorbid irritable bowel syndrome and generalized anxiety disorder. Tollefson GD, Luxenberg M, Valentine R, Dunsmore G, Tollefson SL. J Clin Psychiatry; 1991 Dec 02; 52(12):502-8. PubMed ID: 1752852 [Abstract] [Full Text] [Related]
38. Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial. Hadley SJ, Mandel FS, Schweizer E. J Psychopharmacol; 2012 Apr 02; 26(4):461-70. PubMed ID: 21693549 [Abstract] [Full Text] [Related]
39. [Alprazolam in the treatment of anxiety disorders and mixed anxiety and depressive disorders. Results of multicenter clinical trial]. Kiejna A, Małyszczak K, Rzewuska M, Sobucka K, Florkowski A, Rajewski A, Rajewska J, Wojtanowska M, Dabkowski M, Brzeziński R, Rybakowski J, Sep-Kowalikowa B, Gałuszko P, Nowicki Z. Psychiatr Pol; 1996 Apr 02; 30(6):973-92. PubMed ID: 9132771 [Abstract] [Full Text] [Related]
40. A homoeopathic proving of Galphimia glauca. Teut M, Dahler J, Schnegg C, Wilsede Study Group for Homoeopathic Provings. Forsch Komplementmed; 2008 Aug 02; 15(4):211-7. PubMed ID: 18787330 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]